SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe

← ETF Screener

GERM ETFMG Treatments, Testing and Advancements ETF

Issuer
Amplify
Inception
Jun 18, 2020
AUM
$9.7M
Expense ratio
0.68%
Yield
—
Asset class
Equity
Holdings
57
Last price
$19.16

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

No price history on file.

Performance

1M3MYTD1Y3Y ann.5Y ann.
GERM+3.0%-3.3%-1.3%+1.1%——
Equity average (4726 funds)-2.4%-5.0%+4002.3%+2568.4%+14.2%+3.7%

Insider activity in the holdings

Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$24K net.

HoldingWeightInsiders boughtInsiders sold
XBIT XBiotech Inc0.48%$855K$0
ALNY Alnylam Pharmaceuticals Inc11.39%$543K$399K
CRMD CorMedix Inc0.49%$391K$0
CVM CEL-SCI Corp0.16%$138K$0
ZLAB Zai Lab Ltd3.60%$33K$7K
ANTX AN2 Therapeutics Inc0.07%$12K$117K

Holdings · as of Aug 11, 2024

#HoldingWeight
1ALNY Alnylam Pharmaceuticals Inc11.39%
2LH Labcorp Holdings Inc7.20%
3DGX Quest Diagnostics Inc6.61%
4BNTX BioNTech SE5.01%
5BIO Bio-Rad Laboratories Inc4.74%
6PCVX Vaxcyte Inc4.52%
7QDEL QuidelOrtho Corp4.11%
8BCRX BioCryst Pharmaceuticals Inc3.70%
9IMCR Immunocore Holdings PLC3.67%
10ZLAB Zai Lab Ltd3.60%
11MRNA Moderna Inc3.46%
12DVAX Dynavax Technologies Corp3.42%
13IBRX ImmunityBio Inc3.14%
14VIR Vir Biotechnology Inc2.79%
15NVAX Novavax Inc2.50%
16OPK OPKO Health Inc2.46%
17CVAC CureVac NV1.73%
18FLGT Fulgent Genetics Inc1.68%
19ABUS Arbutus Biopharma Corp1.62%
20ADPT Adaptive Biotechnologies Corp1.55%
21SIGA SIGA Technologies Inc1.45%
22ARCT Arcturus Therapeutics Holdings Inc1.14%
23GILD Gilead Sciences Inc1.01%
24REGN Regeneron Pharmaceuticals Inc0.99%
25ABBV AbbVie Inc0.98%
26JNJ Johnson & Johnson0.96%
27LLY Eli Lilly & Co0.93%
28SNY Sanofi SA0.92%
29ABT Abbott Laboratories0.91%
30TAK Takeda Pharmaceutical Co Ltd0.89%
31AZN AstraZeneca PLC0.88%
32EBS Emergent BioSolutions Inc0.87%
33PFE Pfizer Inc0.86%
34GSK GSK PLC0.84%
35MRK Merck & Co Inc0.76%
36OCGN Ocugen Inc0.76%
37OSUR OraSure Technologies Inc0.73%
38AVIR Atea Pharmaceuticals Inc0.66%
39ENTA Enanta Pharmaceuticals Inc0.62%
40INO Inovio Pharmaceuticals Inc0.52%
41CRMD CorMedix Inc0.49%
42XBIT XBiotech Inc0.48%
43CASH&OTHER Cash & Other0.35%
44AGPXX Invesco Government & Agency Portfolio 12/31/20310.35%
45IVVD Invivyd Inc0.29%
46VXRT Vaxart Inc0.24%
47RENB Renovaro Inc0.22%
48IFRX InflaRx NV0.19%
49HLVX HilleVax Inc0.19%
50CMRX Chimerix Inc0.18%
51CVM CEL-SCI Corp0.16%
52GRTS Gritstone bio Inc0.13%
53CUE Cue Biopharma Inc0.07%
54ANTX AN2 Therapeutics Inc0.07%
55SCLX Scilex Holding Co0.00%
562298465D Gurnet Point Capital LLC0.00%
572334482D AstraZeneca PLC0.00%

Sector breakdown

Not on file.

Country breakdown

Not on file.

Distributions

No distributions on file.

Members of Congress who disclosed this ETF

No member of Congress has disclosed a trade in GERM in the filings we hold.

Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 16, 2026. This is historical data, not investment advice. Report a data error